Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Decrease of proinflammatory molecules correlates with neuroprotective effect of the fluorinated salicylate triflusal

Laia Acarin1, Berta González, Bernardo Castellano

  • 1Unit of Histology, School of Medicine, Department of Cell Biology, Physiology, and Immunology, Autonomous University of Barcelona, Bellaterra, Spain. laia.acarin@uab.es

Stroke
|October 5, 2002
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Roadmap for Postnatal Brain Maturation: Changes in Gray and White Matter Composition during Development Measured by Fourier Transformed Infrared Microspectroscopy.

ACS chemical neuroscience·2023
Same author

Younger age and induction failure predict outcomes in infant leukemia: 30 years of experience in a tertiary center.

Frontiers in pediatrics·2023
Same author

Decoding the molecular heterogeneity of pediatric monomorphic post-solid organ transplant lymphoproliferative disorders.

Blood·2023
Same author

Microglia states and nomenclature: A field at its crossroads.

Neuron·2022
Same author

Tisagenlecleucel therapy for relapsed or refractory B-cell acute lymphoblastic leukaemia in infants and children younger than 3 years of age at screening: an international, multicentre, retrospective cohort study.

The Lancet. Haematology·2022
Same author

Astrocyte-targeted Overproduction of IL-10 Reduces Neurodegeneration after TBI.

Experimental neurobiology·2022

Triflusal reduces brain damage after excitotoxic injury by decreasing inflammatory molecules like inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2). This suggests triflusal as a potential therapeutic for neurodegenerative conditions.

Area of Science:

  • Neuroscience
  • Pharmacology

Background:

  • Excitotoxic brain injury in postnatal development leads to secondary damage.
  • Inflammatory mediators like interleukin-1beta (IL-1beta), tumor necrosis factor-alpha (TNF-alpha), inducible nitric oxide synthase (iNOS), and cyclooxygenase-2 (COX-2) are implicated in this damage.

Purpose of the Study:

  • To investigate if the neuroprotective effect of triflusal is linked to changes in the expression of key inflammatory molecules.
  • To assess the impact of triflusal on iNOS, COX-2, IL-1beta, and TNF-alpha following an excitotoxic lesion.

Main Methods:

  • Postnatal rats received an N-methyl-D-aspartate excitotoxic lesion.
  • Triflusal was administered orally 8 hours post-lesion.
  • Immunohistochemistry was used to analyze the expression of iNOS, COX-2, IL-1beta, and TNF-alpha at 10 and 24 hours post-lesion.

Related Experiment Videos

Main Results:

  • Triflusal significantly reduced the neurodegenerative area.
  • A strong decrease in inducible nitric oxide synthase (iNOS) immunolabeling was observed in glial cells and neutrophils.
  • Moderate reductions in cyclooxygenase-2 (COX-2), interleukin-1beta (IL-1beta), and tumor necrosis factor-alpha (TNF-alpha) expression were noted.

Conclusions:

  • Triflusal-mediated neuroprotection involves the downregulation of iNOS and other inflammatory mediators.
  • Triflusal shows promise as a therapeutic agent for conditions where regulating inflammatory gene expression is crucial for neurodegenerative outcomes.